Cargando…

Advances in managing COPD related to α(1)‐antitrypsin deficiency: An under‐recognized genetic disorder

α(1)‐Antitrypsin deficiency (AATD) predisposes individuals to chronic obstructive pulmonary disease (COPD) and liver disease. Despite being commonly described as rare, AATD is under‐recognized, with less than 10% of cases identified. The following is a comprehensive review of AATD, primarily for phy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craig, Timothy J., Henao, Maria Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282978/ https://www.ncbi.nlm.nih.gov/pubmed/29984428 http://dx.doi.org/10.1111/all.13558

Ejemplares similares

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

Targeted screening programmes in COPD: how to identify individuals with α(1)-antitrypsin deficiency
por: Chorostowska-Wynimko, Joanna
Publicado: (2015)

Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)

Longer Telomere Length in COPD Patients with α(1)-Antitrypsin Deficiency Independent of Lung Function
por: Saferali, Aabida, et al.
Publicado: (2014)

Diagnosis and management of α(1)-antitrypsin deficiency in Europe: an expert survey
por: Horváth, Ildikó, et al.
Publicado: (2019)

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
por: Zhumagaliyeva, Ardak, et al.
Publicado: (2017)

ATZ11 Recognizes Not Only Z-α(1)-Antitrypsin-Polymers and Complexed Forms of Non-Z-α(1)-Antitrypsin but Also the von Willebrand Factor
por: Goltz, Diane, et al.
Publicado: (2014)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency
por: Teckman, Jeffrey, et al.
Publicado: (2014)

Ruptured Gastric Aneurysm in α-1 Antitrypsin Deficiency
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2016)

Molecular Mechanism of Z α1-Antitrypsin Deficiency
por: Huang, Xin, et al.
Publicado: (2016)

Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?
por: Godoy, Irma
Publicado: (2016)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
por: Russo, Rodrigo, et al.
Publicado: (2016)

Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States
por: Sieluk, Jan, et al.
Publicado: (2020)

Stem cell-based therapy for α(1)-antitrypsin deficiency
por: Rashid, S Tamir, et al.
Publicado: (2012)

Deficiency of α-1-antitrypsin influences systemic iron homeostasis
por: Ghio, Andrew J, et al.
Publicado: (2013)

Flecainide and elevated liver enzymes in α1-antitrypsin deficiency
por: Jenkins, David J.A., et al.
Publicado: (2016)

COVID-19 vaccination in patients with α1-antitrypsin deficiency
por: Yang, Chengliang, et al.
Publicado: (2021)

The emerging role of proteases in α(1)-antitrypsin deficiency and beyond
por: Fazleen, Aishath, et al.
Publicado: (2021)

The effect of exacerbations on lung density in α(1)-antitrypsin deficiency
por: Strange, Charlie, et al.
Publicado: (2023)

The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
por: Pini, Laura, et al.
Publicado: (2014)

Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD
por: Balbi, Bruno, et al.
Publicado: (2019)

Lung microhaemorrhage drives oxidative/inflammatory damage in α(1)-antitrypsin deficiency
por: Saltini, Cesare, et al.
Publicado: (2023)

Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
por: Onur, Seda Tural, et al.
Publicado: (2022)

Relationship Between α(1)-Antitrypsin Deficiency and Ascending Aortic Distention
por: Dako, Farouk, et al.
Publicado: (2021)

Diagnosing α(1)-antitrypsin deficiency: how to improve the current algorithm
por: McElvaney, Noel G.
Publicado: (2015)

α(1)-Antitrypsin deficiency associated with increased risk of heart failure
por: Winther, Sine V., et al.
Publicado: (2023)

Alpha(1)-antitrypsin deficiency: a clinical-genetic overview
por: Abboud, Raja T, et al.
Publicado: (2011)

Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death
por: Kats-Ugurlu, Gursah, et al.
Publicado: (2010)

Iodine Deficiency: An under Recognized Problem
por: Prabhu, Sudha Rathna, et al.
Publicado: (2017)

Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD
por: Hampson, Judith A., et al.
Publicado: (2016)

Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients ‘on’ or ‘off’ augmentation therapy
por: Olfert, I Mark, et al.
Publicado: (2014)

Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common
por: ÇÖRTÜK, Mustafa, et al.
Publicado: (2022)

A specific proteinase 3 activity footprint in α(1)-antitrypsin deficiency
por: Newby, Paul R., et al.
Publicado: (2019)

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
por: Yang, Chengliang, et al.
Publicado: (2021)

Diffuse panniculitis in a teenage male with ZZ α(1)-antitrypsin deficiency
por: Papiris, Spyros A., et al.
Publicado: (2023)

Occupational COPD—The most under‐recognized occupational lung disease?
por: Murgia, Nicola, et al.
Publicado: (2022)

Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.
por: Sharp, Richard R, et al.
Publicado: (2003)

Prevalence of α(1)-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review
por: Blanco, Ignacio, et al.
Publicado: (2020)

Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine
por: Hersh, Craig P.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cem7u8401qe46i4mcubrd1m0jc